计算溶液所需的质量、体积或浓度。
为什么选择此级别
，适用于对基线干扰要求严格的色谱和分析工作流程。
储存与运输
-80℃储存,避免反复冻融。特低温运输 。请查阅批次 COA 获取详细规格。
质量文档
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
文献证明
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
概述
Protein Purity
>95% by SDS-PAGE
Extinction Coeff.
A276 nm = 0.456 at 1.0 mg/mL
Molecular Weight
8,603 Da (single chain)
General Description
Natural human C4a is prepared by cleavage of human C4 protein by human C1s. It is produced during activation of both the classical and lectin pathways of complement. C4a
is a member of the anaphylatoxin family of three proteins (C3a, C4a and C5a) produced by the activation of complement (Hugli, T.E. et al. (1981)). Removal of the C-terminal arginine by serum carboxypeptidase N (Meuller-Ortiz, S.L., et al. (2009)) yields C4a desArg and destroys all biological activities of C4a. C4a desArg is an unglycosylated polypeptidecontaining 76 amino acids with a molecular mass of 8,603 daltons.
Physical Characteristics & Structure
Molecular weight: 8,603 calculated molecular mass. Observed mass (MALDI-TOF) is 8,606 + 9 mass units. pI = 9.0 to 9.5 (Gorski, J.P. et al. (1981))Amino acid sequence (76 amino acids): NVNFQKAINE KLGQYASPTA KRCCQDGVTR LPMMRSCEQR AARVQQPDCR EPFLSCCQFA ESLRKKSRDK GQAGLQ
C4a and C4a desArg are thought to be structurally very similar to C3a and C5a to which they are homologous. Thus the 3D structure is probably similar to the X-ray-derived crystal structure of C3a (Huber, R. et al. (1980)) and the NMR derived structure of C3a: Nettesheim, D.G. et al. (1988); Murray, I. et al. (1999).
Function
See General Description above. C4a desArg is functionally inactive form of C4a. C4a exhibits much weaker biological activities than C3a and C5a. Its activity in inducing erythema and edema in human skin is 25,000-fold weaker than that of C5a and 100-fold weaker than C3a per nanomole. The spasmogenic activity of C4a is 2000-fold weaker than C5a and 100-fold weaker than that of C3a. Due to these differences the role of C4a in theseresponses in vivo is thought to be negligible even before inactivation to C4a desArg.
Assays
C4a desArg is the inactivated form of C4a, which as described above, exhibits orders of magnitude less activity than C3a and C5a. Thus, no biological activity is thought to be exhibited by C4a desArg.ELISA kits for the assay of C4a levels (or more correctly C4a desArg levels) in blood and other fluids are commercially available. These measurements are useful for detecting complement activation in vivo, but the interpretation of their meaning is complicated by the
fact that clearance of the anaphylatoxins is rapid.
In vivo
Freshly drawn normal human serum contains significant levels of all three anaphylatoxins. Although these may represent the resting concentration in vivo it is difficult to draw or store blood without some complement activation so a true in vivo concentration is difficult to determine. The presence of EDTA and Futhan in the collection tubes can minimize this background (Pfeifer, P.H. et al. (1999)). Full activation of all C4 in blood (600µg/mL) would result in ~3,400 nM C4a desArg (~30 µg/mL). Due to the low biological activity of C4a and C4a desArg it could require activation of most of the C4 in a small region to achieve the micromolar C4a concentrations necessary to elicit a response.
Regulation
C4a and C4a desArg levels are regulated by three processes: formation, inactivation and clearance. There are two enzymes that cleave C4 and release C4a: C1s and MASP-2. C4a is “inactivated” by removal of its C-terminal arginine amino acid to make C4a desArg.Because C4a desArg does not bind to the C3a/C4a receptor it is probably not captured, internalized and digested like the other anaphylatoxins. Filtration by the kidney is a likely mode of clearance.
Diseases
There are no known diseases connected to C4a or C4a desArg.
Precautions/Toxicity/Hazards
The source of C4a is human serum, therefore appropriate precautions must be observed even though the source was shown by certified tests to be negative for HBsAg, HTLV-I/II, STS, and for antibodies to HCV, HIV-1 and HIV-II.Injection can cause anaphylatic shock which is a generalized circulatory collapse similar to that caused by an allergic reaction.
Hazard Code: B WGK Germany 3
规格
产品名称
C4a des Arg Anaphylatoxin (Not Recombinant)
别名
C4a des Arg 过敏毒素(非重组)
规格或纯度
0.5 mg/mL,Presence of desArg: ＜ 3 %
分子类型
蛋白质
产品线
生物产品
储存与运输
储存缓冲液
HEPES buffered saline, pH 7.2 (No carrier proteins added)
浓度
0.5 mg/mL,Presence of desArg: ＜ 3 %
储存条件
-80℃储存,避免反复冻融
运输条件
特低温运输
技术文档
高级数据
质检证书（CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
溶液计算器
产品仅提供给经过验证的企业、机构和合格的专业人员用于研发。不适用于人类、动物、诊断或治疗。
Copyright © 2023至今 上海阿拉丁生化科技股份有限公司 保留所有权利。
危险品化学品经营许可证（带存储）